Grange2001 - L Dopa PK model Lab

{
  "io": {
    "inputs": [
      {
        "name": "l_dopa_dose_per_kg_rat",
        "label": "L Dopa Dose Per Kg Rat",
        "maps_to": "pharmacology_sbml_grange2001_l_dopa_pk_model_biomd0000000321_model.l_dopa_dose_per_kg_rat"
      },
      {
        "name": "l_dopa_clearance_rate",
        "label": "L Dopa Clearance Rate",
        "maps_to": "pharmacology_sbml_grange2001_l_dopa_pk_model_biomd0000000321_model.l_dopa_clearance_rate"
      },
      {
        "name": "omd_clearance_rate",
        "label": "Omd Clearance Rate",
        "maps_to": "pharmacology_sbml_grange2001_l_dopa_pk_model_biomd0000000321_model.omd_clearance_rate"
      }
    ],
    "outputs": [
      {
        "name": "state",
        "label": "Tracked source state",
        "maps_to": "pharmacology_sbml_grange2001_l_dopa_pk_model_biomd0000000321_model.state"
      },
      {
        "name": "summary",
        "label": "Simulation summary",
        "maps_to": "pharmacology_sbml_grange2001_l_dopa_pk_model_biomd0000000321_model.summary"
      },
      {
        "name": "species_labels",
        "label": "Observable labels",
        "maps_to": "pharmacology_sbml_grange2001_l_dopa_pk_model_biomd0000000321_model.species_labels"
      },
      {
        "name": "l_dopa_amount",
        "label": "L Dopa Amount",
        "maps_to": "pharmacology_sbml_grange2001_l_dopa_pk_model_biomd0000000321_model.l_dopa_amount"
      },
      {
        "name": "l_dopa_concentration",
        "label": "L Dopa Concentration",
        "maps_to": "pharmacology_sbml_grange2001_l_dopa_pk_model_biomd0000000321_model.l_dopa_concentration"
      },
      {
        "name": "three_omd_concentration",
        "label": "Three Omd Concentration",
        "maps_to": "pharmacology_sbml_grange2001_l_dopa_pk_model_biomd0000000321_model.three_omd_concentration"
      }
    ]
  },
  "tags": [
    "pharmacology",
    "pharmacokinetics",
    "neuroscience",
    "pbpk",
    "sbml",
    "tellurium",
    "faithful",
    "biomodels_ebi"
  ],
  "title": "Grange2001 - L Dopa PK model Lab",
  "models": [
    {
      "path": "models/core",
      "alias": "pharmacology_sbml_grange2001_l_dopa_pk_model_biomd0000000321_model",
      "parameters": {
        "model_path": "data/BIOMD0000000321.xml",
        "integration_step": 0.1
      }
    },
    {
      "path": "models/visualisation",
      "alias": "visualisation"
    }
  ],
  "wiring": [
    {
      "to": [
        "visualisation.pharmacology_sbml_grange2001_l_dopa_pk_model_biomd0000000321_model_state"
      ],
      "from": "pharmacology_sbml_grange2001_l_dopa_pk_model_biomd0000000321_model.state"
    },
    {
      "to": [
        "visualisation.pharmacology_sbml_grange2001_l_dopa_pk_model_biomd0000000321_model_summary"
      ],
      "from": "pharmacology_sbml_grange2001_l_dopa_pk_model_biomd0000000321_model.summary"
    },
    {
      "to": [
        "visualisation.pharmacology_sbml_grange2001_l_dopa_pk_model_biomd0000000321_model_species_labels"
      ],
      "from": "pharmacology_sbml_grange2001_l_dopa_pk_model_biomd0000000321_model.species_labels"
    }
  ],
  "package": "grange2001-ldopa-pk",
  "runtime": {
    "duration": 24,
    "initial_inputs": {},
    "communication_step": 1
  },
  "version": "1.0.0",
  "description": "Grange2001 - L-dopa PK model A pharmacokinetics of L-dopa in rats after administration of L-dopa alone (this model: BIOMD0000000321) or L-dopa combined with a peripheral AADC (amino-acid-decarboxylase. It can be used to explore dose-response dynamics and compare treatment scenarios across conditions.",
  "schema_version": "2.0"
}